Search All UT System Experts

Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation)

Pearlie P. Chong, Dagny Teiber, Bonnie C. Prokesch, Reuben J. Arasaratnam, Matthias Peltz, Mark H. Drazner, Sonia Garg

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation)'. Together they form a unique fingerprint.

Medicine & Life Sciences